Climate targets imply a dramatic transformation of the global energy system, yet fossil fuels are likely to remain part of it for decades. Professor Myles Allen CBE FRS, Professor of Geosystem Science at the University of Oxford, explores what this apparent contradiction means for climate policy and the future of oil and gas, including the contested UK developments at Jackdaw and Rosebank.

Each year the Richard Hillary Memorial Lecture is given by notable creative writers and remembers Richard Hillary, the author of The Last Enemy, who was a student at Trinity. The event is free and open to all.

This year's lecture will be given by Jhumpa Lahiri. 

Join acclaimed broadcaster and author James Naughtie to explore the fallout of the US midterm elections – what they mean for the remainder of Donald Trump’s Presidency and what might lie beyond. As the dust settles on the vote just two weeks before, Naughtie will use his decades of experience reporting on American politics to unpack what the results mean for a deeply divided nation – from shifting power dynamics in Washington to the broader cultural and social currents shaping everyday life.

With The Rt Hon Liam Byrne MP, Professor Jane Green FAcSS FAAAS and Richard Foster

Join acclaimed actress Greta Scacchi, actor and director Philip Franks and scholar Dan Rebellato to explore the life, work and enduring significance of Trinity alumnus Terence Rattigan. Once dismissed as old-fashioned, Rattigan's plays—including The Winslow Boy, The Deep Blue Sea and, most recently at the National Theatre, Man and Boy—have undergone a remarkable critical revival, celebrated for their emotional precision and subtle social critique.

This talk tells an Oxford story, from the discovery and development of penicillin to the modern clinical evaluation of treatments for COVID-19 and other common viral infections. It explores how one of medicine’s great miracles also led to one of its great mistakes: the overuse of antimicrobials and the rise of resistance. Drawing on recent Oxford-led community-based clinical trials, Chris will argue that we must not repeat the same error with the new treatments for viral infections now coming to market at pace.